FindTrial
Sign In

Early detection of Vulvar precancer in women with HPV using a special examination technique

Clinical utility of the three ring vulvoscopy as a screening tool for the detection of vulvar intraepithelial neoplasia in HPV positive female - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/102856
Enrollment
70
Registered
2026-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C519- Malignant neoplasm of vulva, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed HPV positive status by HPV DNA testing or pap smear. 3. Patients who have not undergone vulvar surgery or ablation therapy in last 6 months. 4.Consent to participate

Exclusion criteria

Exclusion criteria: 1.Antenatal female. 2.Women with known vulvar carcinoma. 3.Age less than 30 years. 4.Women with recent vulvar surgery (within last 6 months) . 5.Women with active vulvar infections or severe inflammation(genital herpes or candidiasis) 6.Contraindication or allergy to acetic acid. 7.Refusal to give consent.

Design outcomes

Primary

MeasureTime frame
evaluate effectiveness of threering Vulvoscopy in detecting VIN in HPV positive females with normal vulval examination. Secondary objective: Timepoint: 3 weeks after tests—

Secondary

MeasureTime frame
1.To evaluate correlation between lesion, location & its association with severity of VIN lesions. 2.To find out lesions other than VIN in HPV positive females. 3.To correlate VIN with cervical cytology abnormalities. Timepoint: 4weeks—

Countries

India

Contacts

Public ContactDrbharti joshi

PGIMER

drbhartijoshi09@gmail.com6281014571

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026